Skip to main content

Advertisement

Table 4 CLART results for 4,410 primary a samples, by age, screening history, cytology, and HC2 results

From: HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system

  Outcomes on CLART, N (%)
Any high-risk genotype (%)b No high-risk genotypes (%)c Only low-risk genotypes (%)b Invalid (%) Total (%)
Total 1,024 (23.2%) 3,375 (76.5%) 528 (12.0%) 11 (0.2%) 4,410 (100%)
Age (years)      
16-22 77 (57.0%) 58 (43.0%) 18 (13.3%) 0 (0.0%) 135 (100%)
23-29 485 (37.7%) 801 (62.2%) 175 (13.6%) 1 (0.1%) 1,287 (100%)
30-39 274 (21.1%) 1,021 (78.6%) 139 (10.7%) 4 (0.3%) 1,299 (100%)
40-49 116 (12.8%) 783 (86.6%) 104 (11.5%) 5 (0.6%) 904 (100%)
50-59 45 (9.7%) 419 (90.1%) 55 (11.8%) 1 (0.2%) 465 (100%)
60-65 19 (8.8%) 196 (91.2%) 22 (10.2%) 0 (0.0%) 215 (100%)
>65 8 (7.6%) 97 (92.4%) 15 (14.3%) 0 (0.0%) 105 (100%)
Cytology      
Normal 847 (20.4%) 3,290 (79.3%) 494 (11.9%) 11 (0.3%) 4,148 (100%)
ASCUS 49 (57.6%) 36 (42.4%) 9 (10.6%) 0 (0.0%) 85 (100%)
LSIL 64 (73.6%) 23 (26.4%) 20 (23.0%) 0 (0.0%) 87 (100%)
≥HSIL 64 (92.8%) 5 (7.2%) 2 (2.9%) 0 (0.0%) 69 (100%)
≥ASCUS 177 (73.4%) 64 (26.6%) 31 (12.9%) 0 (0.0%) 241 (100%)
Inadequate 0 (0.0%) 21 (100%) 3 (14.3%) 0 (0.0%) 21 (100%)
HC2 d      
Positive 693 (84.3%) 128 (15.6%) 84 (10.2%) 1 (0.1%) 822 (100%)
Negative 330 (9.2%) 3,245 (90.5%) 444 (12.4%) 10 (0.3%) 3,585 (100%)
  1. Abbreviations: ASCUS atypical squamous cells of undetermined significance, HC2 Hybrid Capture 2 assay, HPV Human Papillomavirus, ≥HSIL high-grade intraepithelial lesions or worse, LSIL low-grade squamous intraepithelial lesions.
  2. aPredominantly screening samples, including a small proportion of samples taken for indication.
  3. bAccording to classification reported by IARC [2].
  4. cConsidered negative on the CLART assay.
  5. dThree samples were not tested with HC2.